Expert Conversations: Cost Effectiveness of Adhering to Guidelines for Treating CAP
In this podcast, Forest Arnold, MD, and Michael Egger, MD, speak about their study that aimed to evaluate the cost-effectiveness of adhering to treatment guidelines for community-acquired bacterial pneumonia in elderly patients who are hospitalized, including how the results of their study will impact clinical practice going forward.
- Egger ME, Myers JA, Arnold FW, Pass LA, Ramirez JA, Brock GN. Cost effectiveness of adherence in IDSA/ATS guidelines in elderly patients hospitalized for community-acquired pneumonia. BMC Med Inform Decis Mak. Published online March 15, 2016. https://doi.org/10.1186/s12911-016-0270-y
- Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumona. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45-e67. https://doi.org/10.1164/rccm.201908-1581st
Disclaimer: Since this study was published, updated guidelines on pneumonia have been published. The views expressed in this podcast are based on the research paper published in 2016 and do not reflect the new guidelines.
Forest Arnold, MD, is an associate professor in the Division of Infectious Diseases at the University of Louisville in Louisville, Kentucky.
Michael Egger, MD, is an assistant professor in the Division of Surgical Oncology at the University of Louisville in Louisville Kentucky.